Logo image of SBNY

SIGNATURE BANK (SBNY) Stock Fundamental Analysis

NASDAQ:SBNY - Nasdaq - US82669G1040 - Common Stock - Currency: USD

70  -20.76 (-22.87%)

Premarket: 69.62 -0.38 (-0.54%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SBNY. SBNY was compared to 395 industry peers in the Banks industry. While SBNY is still in line with the averages on profitability rating, there are concerns on its financial health. SBNY scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SBNY was profitable.
In the past year SBNY had a positive cash flow from operations.
SBNY had positive earnings in 4 of the past 5 years.
SBNY had a positive operating cash flow in 4 of the past 5 years.
SBNY Yearly Net Income VS EBIT VS OCF VS FCFSBNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

1.2 Ratios

SBNY's Return On Assets of 1.11% is in line compared to the rest of the industry. SBNY outperforms 51.33% of its industry peers.
SBNY has a better Return On Equity (16.54%) than 84.57% of its industry peers.
Industry RankSector Rank
ROA 1.11%
ROE 16.54%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBNY Yearly ROA, ROE, ROICSBNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

SBNY has a better Profit Margin (49.26%) than 98.94% of its industry peers.
In the last couple of years the Profit Margin of SBNY has grown nicely.
SBNY does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 49.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.51%
PM growth 5Y5.73%
GM growth 3YN/A
GM growth 5YN/A
SBNY Yearly Profit, Operating, Gross MarginsSBNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

SBNY does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for SBNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SBNY Yearly Shares OutstandingSBNY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
SBNY Yearly Total Debt VS Total AssetsSBNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B 100B

2.2 Solvency

SBNY has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.58, SBNY belongs to the best of the industry, outperforming 88.03% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that SBNY is not too dependend on debt financing.
SBNY's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. SBNY outperforms 76.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.58
Altman-Z N/A
ROIC/WACCN/A
WACC7.92%
SBNY Yearly LT Debt VS Equity VS FCFSBNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBNY Yearly Current Assets VS Current LiabilitesSBNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

SBNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.94%, which is quite impressive.
SBNY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.26% yearly.
The Revenue has grown by 39.46% in the past year. This is a very strong growth!
The Revenue has been growing by 10.96% on average over the past years. This is quite good.
EPS 1Y (TTM)41.94%
EPS 3Y17.61%
EPS 5Y15.26%
EPS Q2Q%43.56%
Revenue 1Y (TTM)39.46%
Revenue growth 3Y14.04%
Revenue growth 5Y10.96%
Sales Q2Q%40.1%

3.2 Future

SBNY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.56% yearly.
SBNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.98% yearly.
EPS Next Y42.69%
EPS Next 2Y-0.32%
EPS Next 3Y2.56%
EPS Next 5YN/A
Revenue Next Year36.38%
Revenue Next 2Y12.21%
Revenue Next 3Y10.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SBNY Yearly Revenue VS EstimatesSBNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
SBNY Yearly EPS VS EstimatesSBNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.54, the valuation of SBNY can be described as very cheap.
SBNY's Price/Earnings ratio is rather cheap when compared to the industry. SBNY is cheaper than 94.68% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.21, SBNY is valued rather cheaply.
The Price/Forward Earnings ratio is 4.69, which indicates a rather cheap valuation of SBNY.
91.76% of the companies in the same industry are more expensive than SBNY, based on the Price/Forward Earnings ratio.
SBNY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.70.
Industry RankSector Rank
PE 3.54
Fwd PE 4.69
SBNY Price Earnings VS Forward Price EarningsSBNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SBNY is valued cheaply inside the industry as 82.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.56
EV/EBITDA N/A
SBNY Per share dataSBNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

SBNY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.08
PEG (5Y)0.23
EPS Next 2Y-0.32%
EPS Next 3Y2.56%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.19%, SBNY has a reasonable but not impressive dividend return.
In the last 3 months the price of SBNY has falen by -40.96%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
SBNY's Dividend Yield is slightly below the industry average, which is at 3.47.
SBNY's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.19%

5.2 History

SBNY has been paying a dividend for over 5 years, so it has already some track record.
SBNY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
SBNY Yearly Dividends per shareSBNY Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

13.87% of the earnings are spent on dividend by SBNY. This is a low number and sustainable payout ratio.
DP13.87%
EPS Next 2Y-0.32%
EPS Next 3Y2.56%
SBNY Yearly Income VS Free CF VS DividendSBNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M
SBNY Dividend Payout.SBNY Dividend Payout, showing the Payout Ratio.SBNY Dividend Payout.PayoutRetained Earnings

More info and screens

SIGNATURE BANK

NASDAQ:SBNY (3/10/2023, 8:00:02 PM)

Premarket: 69.62 -0.38 (-0.54%)

70

-20.76 (-22.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-17 2023-01-17/bmo
Earnings (Next)04-17 2023-04-17/bmo
Inst Owners0.65%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.40B
Analysts78.26
Price Target155.04 (121.49%)
Short Float %1.49%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 2.19%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP13.87%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.55%
Min EPS beat(2)0.89%
Max EPS beat(2)2.2%
EPS beat(4)4
Avg EPS beat(4)3.99%
Min EPS beat(4)0.89%
Max EPS beat(4)7.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.29%
Min Revenue beat(2)-4.88%
Max Revenue beat(2)-1.7%
Revenue beat(4)1
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)1.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.22%
PT rev (3m)-27.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.58%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.93%
Revenue NY rev (1m)-0.76%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 3.54
Fwd PE 4.69
P/S 1.71
P/FCF 3.56
P/OCF 3.43
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)19.8
EY28.29%
EPS(NY)14.93
Fwd EY21.34%
FCF(TTM)19.67
FCFY28.1%
OCF(TTM)20.43
OCFY29.18%
SpS41.03
BVpS122.21
TBVpS122.21
PEG (NY)0.08
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 16.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 49.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.51%
PM growth 5Y5.73%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr 203.47%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 97.33%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)162.03%
Cap/Depr(5y)151.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)129.62%
Profit Quality(5y)130.1%
High Growth Momentum
Growth
EPS 1Y (TTM)41.94%
EPS 3Y17.61%
EPS 5Y15.26%
EPS Q2Q%43.56%
EPS Next Y42.69%
EPS Next 2Y-0.32%
EPS Next 3Y2.56%
EPS Next 5YN/A
Revenue 1Y (TTM)39.46%
Revenue growth 3Y14.04%
Revenue growth 5Y10.96%
Sales Q2Q%40.1%
Revenue Next Year36.38%
Revenue Next 2Y12.21%
Revenue Next 3Y10.98%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.55%
FCF growth 3Y9.8%
FCF growth 5Y9.09%
OCF growth 1Y40.94%
OCF growth 3Y10.52%
OCF growth 5Y9.26%